Ismail G.
- Country
- Denmark
- Department
- Department of Surgery
Research Overview
- Neoadjuvant Pembrolizumab for Stage I-III dMMR Colon Cancer: A Phase II Organ-Sparing Study
- Calcium electroporation in combination with irreversible electroporation and immunotherapy in patients with pMMR metastatic colorectal cancer - A prospective, phase 2 study
- Evaluation of Propranolol on Preoperative Anxiety and Tumorigenic Gene Expression in Pancreatic Ductal Adenocarcinoma: A Randomized, Triple-Blinded, Placebo-Controlled Pilot Study
Data & Insights
Has run more than one trial at 6 of 18 partner sites.
Specializations
Colorectal Cancer Research
This investigator specializes in developing innovative therapeutic approaches for colorectal cancer treatment, with particular emphasis on neoadjuvant therapies and immunological interventions.
- Electrochemotherapy applications
- Immunotherapy combinations
- Iron deficiency management
The research extends to exploring tumor microenvironment modifications and novel treatment combinations.
Pancreatic Cancer Studies
Focuses on investigating pancreatic ductal adenocarcinoma treatment approaches, incorporating both clinical and psychological aspects of patient care.
- Preoperative anxiety management
- Beta-blocker interventions
- Perioperative care optimization
Integration of translational research with clinical practice in pancreatic cancer treatment.
Immunological Interventions
Investigates advanced immunotherapy approaches in gastrointestinal cancers, including novel combinations and targeted treatments.
- Immune response modulation
- Vaccine-based therapies
- Perioperative immune function
Explores inflammatory conditions and immune system responses in gastrointestinal disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.